Paragon Biosciences is a life science innovator that creates, builds, and funds innovative biology-based companies. Paragon Biosciences focuses on identifying unmet needs in healthcare and developing solutions through its portfolio companies.

Paragon Biosciences

Paragon is a global life science leader that creates, builds and funds innovative biology-based companies. We use biology to accelerate scientific breakthroughs to solve some of society's most challenging medical problems.

Fantastic news from Harmony Biosciences! Congratulations!

Latest research from University of Michigan, the Weizman Institute of Science, and the University of Pennsylvania investigates the early stages of the human central nervous system (CNS). Having a deeper understanding of how the brain and spinal cord develop and communicate could lead to better treatment strategies for people living with CNS disorders.

Encouraged by the work of our portfolio company, Emalex Biosciences, to address a high unmet patient need.

Today, we honor the incredible dedication, compassion, and expertise of our nation's doctors who tirelessly serve patients and communities. Their impact extends far beyond the walls of hospitals, clinics and offices.

Today, we remember and celebrate the impact of visionary leader Dr. Martin Luther King Jr. who dedicated his life to equality, justice, and unity.  #martinlutherkingjr

May the light of the season shine throughout the year!

Congratulations Harmony Biosciences! Well deserved!

Expired or unused prescription medications pose a public safety risk. Safeguard lives and protect the environment by participating in #TakeBackDay on Sat., Oct. 28 from 10 a.m. – 2 p.m. (local time). 

Find a convenient collection site near you at www.DEATakeBack.com.

Metric
Company Name	Paragon Biosciences
Symbol
MSH ID	COM:PARAGONBIOSCI
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology and Pharmaceutical Development
Country	US
Stage
Employee Count	11
Website	paragonbiosci.com
LinkedIn	paragon-biosciences-llc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	601
Web Traffic Growth	-0.75
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

PARA

COM:PARAGONBIOSCI

Paragon Biosciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue